Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma.
Kiyohara E, Tanemura A, Sakura K, Nakajima T, Myoui A, Yamazaki N, Kiyohara Y, Katayama I, Fujimoto M, Kaneda Y. Kiyohara E, et al. Among authors: fujimoto m. Cancer Immunol Immunother. 2022 Aug;71(8):2041-2049. doi: 10.1007/s00262-021-03122-z. Epub 2022 Jan 5. Cancer Immunol Immunother. 2022. PMID: 34984539 Free PMC article. Clinical Trial.
The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients.
Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Fujimoto M, Ohara K. Fujisawa Y, et al. Among authors: fujimoto m. J Dermatol Sci. 2015 Jul;79(1):38-42. doi: 10.1016/j.jdermsci.2015.03.014. Epub 2015 Apr 18. J Dermatol Sci. 2015. PMID: 25944505
A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors.
Ohara K, Fujisawa Y, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Yoshimura K, Fujimoto M. Ohara K, et al. Among authors: fujimoto m. J Dermatol Sci. 2016 Sep;83(3):234-9. doi: 10.1016/j.jdermsci.2016.06.004. Epub 2016 Jun 3. J Dermatol Sci. 2016. PMID: 27329007
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041).
Yamazaki N, Takenouchi T, Fujimoto M, Ihn H, Uchi H, Inozume T, Kiyohara Y, Uhara H, Nakagawa K, Furukawa H, Wada H, Noguchi K, Shimamoto T, Yokota K. Yamazaki N, et al. Among authors: fujimoto m. Cancer Chemother Pharmacol. 2017 Apr;79(4):651-660. doi: 10.1007/s00280-016-3237-x. Epub 2017 Mar 11. Cancer Chemother Pharmacol. 2017. PMID: 28283736 Free PMC article. Clinical Trial.
Case of minocycline-induced hyperpigmentation mimicking angiosarcoma.
Yokoi K, Tanemura A, Takafuji M, Hanaoka Y, Kiyohara E, Fujimoto M. Yokoi K, et al. Among authors: fujimoto m. J Dermatol. 2019 Nov;46(11):e414-e416. doi: 10.1111/1346-8138.14995. Epub 2019 Jun 25. J Dermatol. 2019. PMID: 31237715 No abstract available.
2,454 results